AcuFocus, Inc.
Irvine, US · Delaware corporation · 3 known investors
Founders & leadership
AW
Alan WaterhousePresident and Chief Operating Officer
JT
Jason TesterChief Financial Officer and Secretary
JV
James V. MazzoPresident, Chief Executive Officer and Chairman of the Board
RM
Ryan M. SchwarzNamed on SEC filing
CW
Charles WardenNamed on SEC filing
CL
Charles LarsenNamed on SEC filing
Board
AA
Arjun AroraBoard director
RL
Richard L. Lindstrom, M.D.Board director
WJ
CW
Conrad WangBoard director
BB
Buzz BensonBoard director
JG
James GarveyBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$125.8M disclosed across 7 rounds · 2014–2018
▶$24MraisedAug 2018 · 15 investors · BiotechnologyRule 506(b)
▶$24MraisedAug 2018 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ali SatvatDirector
- Gloria SeftonExecutive Officer
- Conrad WangDirector
- Richard L. Lindstrom, M.D.Director
- William J. LinkDirector
- Buzz BensonDirector
- Arjun AroraDirector
- Greg MaddenDirector
- Alan WaterhouseExecutive Officer, Director
- Offering amount
- $26M
- Amount sold
- $24M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$74.9MraisedOct 2016 · 19 investors · BiotechnologyRule 506(b)
▶$74.9MraisedOct 2016 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alan WaterhouseExecutive Officer, Director
- Buzz BensonDirector
- Arjun AroraDirector
- Jason TesterExecutive Officer
- Richard L. Lindstrom, M.D.Director
- James GarveyDirector
- William J. LinkDirector
- Conrad WangDirector
- Offering amount
- $74.9M
- Amount sold
- $74.9M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedAug 2016 · 15 investors · BiotechnologyRule 506(b)
▶$2MraisedAug 2016 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James GarveyDirector
- William J. LinkDirector
- Charles M. WardenDirector
- Jason TesterExecutive Officer
- Charles LarsenDirector
- Buzz BensonDirector
- Alan WaterhouseExecutive Officer, Director
- Richard L. Lindstrom, M.D.Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedJul 2016 · 14 investors · BiotechnologyRule 506(b)
▶$1.9MraisedJul 2016 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles LarsenDirector
- Richard L. Lindstrom, M.D.Director
- James GarveyDirector
- Ryan M. SchwarzDirector
- Charles WardenDirector
- James V. MazzoExecutive Officer, Director
- Jason TesterExecutive Officer
- Buzz BensonDirector
- Offering amount
- $2.5M
- Amount sold
- $1.9M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.8MraisedMay 2016 · 17 investors · BiotechnologyRule 506(b)
▶$5.8MraisedMay 2016 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles WardenDirector
- Buzz BensonDirector
- Jason TesterExecutive Officer
- Charles LarsenDirector
- James GarveyDirector
- James V. MazzoExecutive Officer, Director
- Richard L. Lindstrom, M.D.Director
- Ryan M. SchwarzDirector
- Offering amount
- $6M
- Amount sold
- $5.8M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedNov 2015 · 11 investors · BiotechnologyRule 506(b)
▶$2MraisedNov 2015 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles LarsenDirector
- Buzz BensonDirector
- James GarveyDirector
- Richard L. Lindstrom, M.D.Director
- Charles WardenDirector
- James V. MazzoExecutive Officer, Director
- Jason TesterExecutive Officer
- Ryan M. SchwarzDirector
- Offering amount
- $5M
- Amount sold
- $2M
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.2MraisedSep 2014 · 20 investors · BiotechnologyRule 506(b)
▶$15.2MraisedSep 2014 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James V. MazzoExecutive Officer, Director
- Buzz BensonDirector
- Richard L. Lindstrom, M.D.Director
- James GarveyDirector
- Jason TesterExecutive Officer
- Ryan M. SchwarzDirector
- Charles WardenDirector
- Charles LarsenDirector
- Offering amount
- $15.7M
- Amount sold
- $15.2M
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are AcuFocus, Inc.'s investors?
- AcuFocus, Inc.'s investors include Evidity Health Capital, Flying L Partners, Versant Venture AIV Holdings.
- How much funding has AcuFocus, Inc. raised?
- AcuFocus, Inc. has disclosed $125.8M raised across 7 rounds.
- Where is AcuFocus, Inc. headquartered?
- AcuFocus, Inc. is headquartered in Irvine, US.